Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant. - Wikidata - wikimedia - TriplyDB

Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.

Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.

http://www.wikidata.org/entity/Q36459340

about

T helper 17 cells promote cytotoxic T cell activation in tumor immunity Tumor-specific Th17-polarized cells eradicate large established melanoma Cigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways.Vesicular stomatitis virus modified with single chain IL-23 exhibits oncolytic activity against tumor cells in vitro and in vivo.IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis.Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses.Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent manners The roles of IL-12 and IL-23 in CD8+ T cell-mediated immunity against Listeria monocytogenes: Insights from a DC vaccination model.Collision tumor of primary laryngeal mucosal melanoma and invasive squamous cell carcinoma with IL-17A and CD70 gene over-expression.An IL12-IL2-antibody fusion protein targeting Hodgkin's lymphoma cells potentiates activation of NK and T cells for an anti-tumor attack.Potentially functional polymorphism in IL-23 receptor and risk of acute myeloid leukemia in a Chinese population Primary mucosal melanoma arising from the eustachian tube with CTLA-4, IL-17A, IL-17C, and IL-17E upregulation Dendritic cell-based vaccines: barriers and opportunities Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination Th17 cells in cancer: help or hindrance?Cell-intrinsic role for IFN-α-STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response.T(H)17 cells in tumour immunity and immunotherapy.Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling TGF-beta and tumors--an ill-fated alliance.Immunotherapy of cancer by IL-12-based cytokine combinations Essentials of Th17 cell commitment and plasticity Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletion.Interleukin-17 and type 17 helper T cells in cancer management and research.Th17 cells: a new therapeutic target in inflammatory dermatoses.Adoptive immunotherapy of cancer using CD4(+) T cells.Ustekinumab in the therapy of chronic plaque psoriasis.IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity Antimelanoma immunotherapy: clinical and preclinical applications of IL-12 family members.Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers.Transient Foxp3(+) regulatory T-cell depletion enhances therapeutic anticancer vaccination targeting the immune-stimulatory properties of NKT cells.An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models.Targeting two co-operating cytokines efficiently shapes immune responses.Assessing the development of murine plasmacytoid dendritic cells in Peyer's patches using adoptive transfer of hematopoietic progenitors.Cytokine-modified VSV is attenuated for neural pathology, but is both highly immunogenic and oncolytic.In support of descriptive studies; relevance to translational research Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.Differential antitumor effect of interleukin-12 family cytokines on orthotopic hepatocellular carcinoma.Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer.

P2860

Q24646584-7275D864-D636-4D26-B16B-BD59078D8D3B Q24648032-B480FD7E-1A4C-44FC-84E7-E92736121F57 Q33642445-277482F2-AE6E-453C-9F7D-72C2A4EA079D Q33913506-CE832FEC-20D7-4A36-9C5E-86B26881B29C Q33929197-F451F804-3552-4622-88D6-0998F2455050 Q33944262-CE7FD3E3-3476-49F1-B211-5F274ED5545F Q33945653-9C074958-CA49-43B4-8CF5-09A2FF0529CD Q33987288-77AB4EFE-C969-4670-B3BA-B9092BE123D9 Q34376431-795B4864-D054-4151-8D8C-16CE54EAD3F8 Q34427113-C328F6E4-43C7-4ED8-8D5B-F21E4B068607 Q34580965-A86B67C2-9D1D-4B19-9678-8942F6B51255 Q34647661-1D68E23C-0983-473C-BE8E-1C1272E26D8E Q34661797-00069F2F-A020-4815-83DA-F95EFC9D3CEF Q34759603-2096642B-11EA-4BBE-813D-52F3D8E899DD Q34913808-EC6F0E7D-98D1-499E-B5CC-4840259D2A42 Q35346365-22F1654B-6B17-4C0B-B080-FCD9CEA8B8BD Q35623903-40D424EA-F260-404A-AC39-4B2E8CE8FCEA Q35674805-2D1D235B-6138-4ABB-9EAF-EFB107C16C98 Q36020084-2CCE55E9-16BE-4E9E-AC4A-B0D748AE4D6E Q36724827-F50E65FE-24D4-4439-9B77-620A9A6FB7B8 Q36730400-1CE3B156-DF0B-4C5C-A2DB-106B1519481E Q36745336-4FD9D118-EF9D-4151-A7FE-FE1AD687FDB6 Q37031654-0C160FD1-F6B0-49AC-8A16-52BD0EE1B053 Q37216488-EAB604FF-A0D9-4D56-A33F-6D316C9AB18B Q37275304-3FF85D8D-8532-45A9-AEA6-1603AAF2B71B Q37303190-48D51A45-C17D-49A8-931B-EAF9CB7BE7FC Q37413874-46C2E7E4-514E-47C0-9E32-C2678FD17FDD Q37793235-EA6FC92E-DD0D-4C9F-9E37-CA7FE94ECBB9 Q38073096-54BDBBF8-1967-4B27-B0CC-DCE7DF5573B8 Q39254820-BCA8B58C-931C-4D61-8A73-92B3F32420EA Q39920448-18A268D5-DA0C-44B7-83FE-A7701949A733 Q40929510-35374739-2AD0-433A-B881-49DB4D5C2536 Q41779828-F181B3A0-A5DB-4BC6-86CE-CF33989DD9C0 Q41829468-59941E9F-87AB-40D5-84CB-6DBA0B53892A Q42786231-AD8AF89E-D19C-47A2-9F6B-8B9A89D91A41 Q45756098-0466EA8C-95E3-429C-9592-A088EE9ADBC8 Q46411431-D7FE411B-3A6B-4E92-AF3F-6793CB8621D8 Q52746279-8A6E40B7-8EB8-458F-8BB5-CF3DC875B878

P2860

Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.

http://www.wikidata.org/entity/Q36459340

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.

@ast

Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.

@en

type

label

Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.

@ast

Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.

@en

prefLabel

Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.

@ast

Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.

@en

P1433

Q36459340-143E7507-0B42-478C-B0CA-B91C860EA62C

P1476

Q36459340-9F8188BF-040A-4FC6-A6A5-52B08BE18DB2

P2093

Q36459340-17CA1FA5-167B-4A97-8826-45711F2A11B6

Q36459340-1D3E9AB4-EC62-4EC6-AB38-7808E3F922AA

Q36459340-2F1CD41F-C536-4A80-95E7-2A6FDD85CF4F

Q36459340-362DE1B6-12C7-483A-93C1-AD626A50C0AD

Q36459340-3CF7B8EF-8112-4368-87A5-CE045E7042FD

Q36459340-44F8746C-49C3-4DB5-9C8E-601F5F9C3075

Q36459340-505F5E7B-DCF8-4A2F-B585-5C76F8E83944

Q36459340-76C23F45-8D17-43C0-9B83-4BD673D1D306

Q36459340-8A90BF30-2869-4031-96AE-0B2CD668E09D

Q36459340-91EFCEEE-FC3A-4971-AC81-9CAB33018479

P2860

Q36459340-0D2E2EB7-DC57-4799-8584-23F3609D94C1

Q36459340-10E25CE4-6D9A-46CF-B461-FF5AC102AC89

Q36459340-13089D7A-8E39-4F3D-B59E-D5F2C775FB7E

Q36459340-15C63CA0-DE34-49E7-82E0-2174CC57F571

Q36459340-1B4310B3-9D29-4229-894B-6F73B491F820

Q36459340-1F13DE71-A779-4EE9-8245-54904AF54BF9

Q36459340-2616426F-82E3-4749-85FF-B458AFD8D750

Q36459340-2B113C8F-0227-45A0-82C9-3CCBF8C51AA0

Q36459340-2B48FF99-19E9-4A85-9518-2FB352D82DE2

Q36459340-2BA49898-D62A-4AB1-98F1-5E620B4A89EC

P304

Q36459340-CB204765-D738-400A-84B2-94BEB0D6B94A

P31

Q36459340-BBBF4DCD-9E42-4DF6-A295-DCFF2C4DD5A6

P356

Q36459340-2F573A91-1A24-4B5A-A9E4-31140285E56A

P407

Q36459340-FF96B646-541D-4DC8-988A-81D7CB8FB99E

P433

Q36459340-7563C3A7-93DC-4E53-9857-FFC63BA75926

P478

Q36459340-A1B7D71B-23BC-41B7-8E89-F73CF7D719A4

P577

Q36459340-E06D4839-437C-4E50-81DA-D98AF1D32BBC

P5875

Q36459340-8D1BA482-2197-4AFA-BB86-0D0B2D07102C

P698

Q36459340-8C2FDF36-050B-42F2-9AC8-5ACCF1DEB7BB

P921

Q36459340-7C6C60C1-E756-4C05-8031-5D9D3E9817D9

P932

Q36459340-F4E9012A-5323-4439-A9FB-93BD7DBD364C

P356

JIMMUNOL.176.9.5213

P1433

Journal of Immunology

P1476

Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.

@en

P2093

Ada M Kruisbeek

http://www.w3.org/2001/XMLSchema#string

Anna M Keller

http://www.w3.org/2001/XMLSchema#string

Bianca Blom

http://www.w3.org/2001/XMLSchema#string

Felicia H Tirion

http://www.w3.org/2001/XMLSchema#string

Jasper G van den Boorn

http://www.w3.org/2001/XMLSchema#string

John B A G Haanen

http://www.w3.org/2001/XMLSchema#string

Karin E de Visser

http://www.w3.org/2001/XMLSchema#string

Laurina A de Jong

http://www.w3.org/2001/XMLSchema#string

Marc R Theoret

http://www.w3.org/2001/XMLSchema#string

Nicholas P Restifo

http://www.w3.org/2001/XMLSchema#string

P2860

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

Cancer immunotherapy: moving beyond current vaccines

Antitumor and antimetastatic activity of IL-23

Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death

IL-23 induces stronger sustained CTL and Th1 immune responses than IL-12 in hepatitis C virus envelope protein 2 DNA immunization

Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients.

The future of interleukin-2: enhancing therapeutic anticancer vaccines

P304

5213-5222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.176.9.5213

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

176

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7158307

http://www.w3.org/2001/XMLSchema#string

P698

16621986

http://www.w3.org/2001/XMLSchema#string

P921

P932

2242845

http://www.w3.org/2001/XMLSchema#string